Yuko Shimizu
Overview
Explore the profile of Yuko Shimizu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
143
Citations
1340
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yata T, Sato G, Ogawa K, Naito T, Sonehara K, Saiki R, et al.
Cell Genom
. 2025 Feb;
5(3):100776.
PMID: 39986280
Neuromyelitis optica spectrum disorder (NMOSD) is a rare autoimmune disease characterized by optic neuritis and transverse myelitis, with an unclear genetic background. A genome-wide meta-analysis of NMOSD in Japanese individuals...
2.
Ikeguchi R, Kanda N, Kobayashi M, Masui K, Nitta M, Misu T, et al.
Mult Scler J Exp Transl Clin
. 2024 Dec;
10(4):20552173241301011.
PMID: 39651331
Background: Few studies have examined B cells among patients with anti-myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD), including brain pathology. Objective: To describe cases of tumefactive MOGAD with B-cell dominant...
3.
Maeda Y, Ikeguchi R, Masui K, Kurata A, Kitagawa K, Shimizu Y
Neuropathology
. 2024 Oct;
PMID: 39475111
Here, we report a case of antineutrophil cytoplasmic antibody (ANCA)-associated central nervous system (CNS) vasculitis that mimicked a brain tumor. The patient presented with progressive right upper arm weakness. Brain...
4.
Niino M, Isobe N, Araki M, Ohashi T, Okamoto T, Ogino M, et al.
Mult Scler Relat Disord
. 2024 Aug;
90:105829.
PMID: 39182455
Background: The previous Japanese clinical practice guidelines for multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) were published in 2017. Recently, for the first time in 6 years, the...
5.
Saito S, Ikeguchi R, Kitagawa K, Shimizu Y
Case Rep Neurol Med
. 2024 Jul;
2024:7808140.
PMID: 39044765
Interferon and glatiramer acetate are the disease-modifying drugs (DMDs) considered relatively safe for use in pregnant women with multiple sclerosis (MS); however, the safety profile of dimethyl fumarate (DMF) and...
6.
Okamoto T, Ishizuka T, Shimizu R, Asahina Y, Nakamura H, Shimizu Y, et al.
JMIR Res Protoc
. 2024 Jan;
13:e46709.
PMID: 38224478
Background: Multiple sclerosis (MS) is an autoimmune inflammatory disease of the central nervous system that causes myelin sheath damage and axonal degeneration. The glycolipid (2S, 3S, 4R)-1-O-(α-d-galactosyl)-2-tetracosanoylamino-1,3,4-nonaetriol (OCH-NCNP1 or OCH)...
7.
Kondo A, Ikeguchi R, Kitagawa K, Shimizu Y
Cureus
. 2023 Dec;
15(12):e49927.
PMID: 38058522
Background This study aimed to clarify the need for disease-modifying drug (DMD) treatment in elderly patients with multiple sclerosis (MS) aged 50 years or older. MS is an autoimmune, demyelinating...
8.
Shimizu Y
Brain Nerve
. 2023 Sep;
75(9):1005-1014.
PMID: 37691241
Multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) are two prevalent autoimmune diseases of the central nervous system that predominantly affect women during childbearing age. Patients of childbearing age...
9.
Examination and reliability of measuring muscle strength of ankle plantar flexion with knee extended
Shimizu Y, Tsutsui S, Katoh M
J Phys Ther Sci
. 2023 Sep;
35(9):619-623.
PMID: 37670756
[Purpose] A hand-held dynamometer (HHD) is less expensive than the isokinetic muscle strength measurement device, and research using HHD is gradually increasing. However, measurement is performed only at a low...
10.
Ito Y, Yoshioka K, Hayashi K, Shimizu Y, Fujimoto R, Yamane R, et al.
Intern Med
. 2023 May;
63(2):159-167.
PMID: 37225482
Objective To assess the prevalence and clinical correlates of non-alcoholic fatty liver disease (NAFLD) identified by computed tomography (CT) in the general population compared with ultrasonography (US). Methods Four hundred...